Florbenazine F 18 clinical trials
Also written 18F-DTBZ and 18F-AV-133.
How each study uses florbenazine F 18 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the florbenazine F 18 studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
14 studies that test it; most in 2010 (3)
| Year | Studies |
|---|---|
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 3 |
| 2015 | 1 |
| 2023 | 1 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 11
Chang Gung Memorial Hospital (7) · Avid Radiopharmaceuticals (3) · Michael J. Fox Foundation for Parkinson's Research (3) · Columbia University (1)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Radiopharmaceuticals source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test florbenazine F 18.
- Sep 2027This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.Phase 2 · Michael J. Fox Foundation for Parkinson's Research
Studies
Open first, then newest update. How each study uses florbenazine F 18 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- This Protocol is a Sub-study Under the PPMI Program. It is a Longitudinal, Single-center Study to Assess the Performance of [18F]AV-133 Imaging Using High and Standard Resolution PET in Individuals Enrolled With Parkinson's Disease (PD) for up to 12 Months.RecruitingPhase 2Michael J. Fox Foundation for Parkinson's ResearchNCT07830654Written as [18F]AV-133
- A Comparative Performance Study Between High and Standard Resolution Positron Emission Tomography Camera Using [18F] AV-133 in Prodromal Parkinson's DiseaseRecruitingPhase 2Michael J. Fox Foundation for Parkinson's ResearchNCT07809438Written as [18F] AV-133 PET Imaging
- Early Longitudinal Imaging in the Parkinson's Progressive Marker Initiative (PPMI) Using (18F)AV-133 (PPMI AV-133 Prodromal Imaging)RecruitingPhase 2Michael J. Fox Foundation for Parkinson's ResearchNCT07265596Written as [18F] AV-133 PET Imaging
- Evaluation of 18 F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell MassCompletedEarly Phase 1Columbia UniversityNCT02236754Written as 18 F-FP-DTBZ
- A Trial of 18F-AV-133 Positron Emission Tomography (PET)TerminatedPhase 1Avid RadiopharmaceuticalsNCT01515384Written as 18F-AV-133
- Investigating the Microstructural and Functional Alterations of Brain in Parkinson's Disease PatientsCompletedPhase 2Chang Gung Memorial HospitalNCT02599753Written as 18-FDTBZ
- Developing a Novel Imaging Biomarker in the Differential Diagnosis of Parkinson's Disease and ParkinsonismCompletedPhase 2Chang Gung Memorial HospitalNCT02059733Written as 18F-DTBZ
- 18F-DTBZ PET and Multi-modal MRI in the Patients With Vascular ParkinsonismCompletedPhase 2Chang Gung Memorial HospitalNCT02195154Written as 18F-DTBZ
- Positron-Emission Tomography With Vesicular Monoamine Transporter Ligand ([18F]-DTBZ) In Healthy Elderly And Young SubjectsCompletedPhase 2Chang Gung Memorial HospitalNCT01838785Written as 18F-DTBZ AV-133
- Imaging Non-motor Symptoms of Parkinson's Disease by Novel 18F-DTBZ and Florbetapir F-18 PETCompletedPhase 2Chang Gung Memorial HospitalNCT02039024Written as 18F- DTBZ
- Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy ControlsCompletedPhase 1Avid RadiopharmaceuticalsNCT01710371Written as 18F-AV-133
- Development of a Novel 18F-DTBZ PET Imaging as a Biomarker to Monitor Neurodegeneration of PARK6 and PARK8 ParkinsonismCompletedPhase 2Chang Gung Memorial HospitalNCT01759888Written as 18F-DTBZ
- 18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET ImagingCompletedPhase 2Chang Gung Memorial HospitalNCT01283347Written as 18F-DTBZ
- A Trial of 18F-AV-133 and 18F-AV-45 Positron Emission Tomography (PET)CompletedPhase 1/2Avid RadiopharmaceuticalsNCT01503944Written as 18F-AV-133
Codes
What other systems call florbenazine F 18 · ClinicalTrials.gg INT005629
- MeSH (NLM) C549477florbenazine F 18Confirmed ClinicalTrials.gov, NLM
- UNII (FDA) KM31LBX59HFLORBENAZINE F-18Confirmed FDA, NLM, Wikidata
- Wikidata Q27282331florbenazine f-18Confirmed FDA, NLM, Wikidata
- NCI Thesaurus C171883Florbenazine F-18One source FDA
- DrugBank DB14945One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C549477 | florbenazine F 18 | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | KM31LBX59H | FLORBENAZINE F-18 | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q27282331 | florbenazine f-18 | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171883 | Florbenazine F-18 | One source FDA |
| DrugBank | DB14945 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.